My previous research has focused on drug design and development in the field of non-addictive analgesics and opioid use disorder treatments. My work has involved molecular design, organic syntheses, in vitro bioscreening, behavior pharmacology, and molecular biology. As a member of Dr. Traynor's lab, my research focuses on the discovery of novel negative allosteric modulators of mu-opioid receptors as OUD treatments.